Nicola Bottoni

Nicola Bottoni

Auto-generated profile, based on publicly available information

Nicola Bottoni

Azienda Unità Sanitaria Locale - IRCCS di Reggio Emilia, Via Amendola 2, Reggio Emilia 42122, Italy

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
SCSalvatore Cozzi
Salvatore Cozzi
NBNicola Bottoni
Nicola Bottoni
ABAndrea Botti
Andrea Botti
VTValeria Trojani
Valeria Trojani
EAEmanuele Alì
Emanuele Alì
CICinzia Iotti
Cinzia Iotti
Background: among cardiac arrhythmias, ventricular tachycardia (VT) is one that can lead to cardiac death, although significant progress has been made in its treatment, including the use of implantable cardioverter-defibrillators (ICD) and radiofrequency catheter ablation. Nevertheless, long-term recurrence rates remain in about half of patients and drastically impact the patient’s quality of life. Moreover, recurrent ICD shocks are painful and are associated with higher mortality and worsening of heart failure. Recently, more and more experiences are demonstrating potential efficacy in the use of stereotactic body radiotherapy (SBRT) (also called cardiac radio-ablation) to treat this condition. In this paper, we report our experience in the use of cardiac radio-ablation for the treatment of refractory ventricular tachycardia with a focus on the technique used, along with a review of the literature and technical notes. Case presentation: an 81-year-old male patient with a long history of non-ischemic dilated cardiomyopathy and mechanical mitral prosthesis underwent a biventricular cardioverter defibrillator implant after atrial ventricular node ablation. At the end of 2021, the number of tachycardias increased significantly to about 10 episodes per day. After failure of medical treatment and conventional RT catheter ablation, the patient was treated with SBRT for a total dose of 25 Gy in a single session at the site of the ectopic focus. No acute toxicity was recorded. After SBRT (follow-up 7 months) no other VT episodes were recorded. Conclusion: SBRT appears to be safe and leads to a rapid reduction in arrhythmic storms as treatment for VT without acute toxicity, representing one of the most promising methods for treating VT storms.

18 March 2023 in EP Europace
Verified
Journal Article
Open access
PDF file
NBNicola Bottoni
Nicola Bottoni
FQFabio Quartieri
Fabio Quartieri
MIMatteo Iori
Matteo Iori
ABAntonella Battista
Antonella Battista
ANAlessandro Navazio
Alessandro Navazio
MBMichele Brignole
Michele Brignole
Aims: While several studies in the literature have reported results of catheter ablation of AF, few is known regarding outcome for more than 10 years. Methods and results: The complete population of patients who underwent AF ablation in the years 2002–2021 in the department of cardiology of the hospital of Reggio Emilia has been analysed. The last follow-up was made in the second half of 2022. During this period the technique of ablation remained relatively unchanged as well the physicians performing ablation. Primary endpoint was the recurrence of symptomatic AF, defined as AF that caused symptoms that were defined by the patient as able to alter their quality of life. 669 patients underwent catheter ablation and 618 were followed until 2022. Median age of the patients was 58 ± 9 years and 521 (78%) were male. There were 407 (61%) of patients with paroxysmal AF, 167 (25%) with persistent AF and 95 (14%) with long-lasting AF. A total of 838 procedures were performed, with a mean of 1.25 per patient. 163 (26%) patients had 2 procedures and 6 had 3 ablations. Periprocedural complications occurred in 4.8% of procedures. Follow-up data were available for 618 patients (92.4%). The median follow-up duration was 6.6 years (IQR 3.2–10.8). The estimated recurrence rate of symptomatic AF was 26% at 10 years, 54% at 15 years and 82% at 20 years. The recurrence rate was similar in patients who had performed one procedure and in those who had performed 2 or 3 procedures. Progression to permanent AF occurred in 112 patients (18%). The major events that occurred during the follow-up consisted of total mortality in 4.5%, heart failure in 3.1% and TIA/stroke in 2.4%. Conclusion: Symptomatic AF tends to recur during long-term follow-up despite one or more procedures. Catheter ablation seems able to reduce the rate of symptomatic recurrences and to delay the time of their occurrence. These findings are consistent with the knowledge that an age-dependent progressive structural atriomiopathy is the basis for the development of AF.

1 November 2020 in Minerva Cardiology and Angiology
Verified
Journal Article
Closed access
MIMatteo Iori
Matteo Iori
FQFabio Quartieri
Fabio Quartieri
ABAntonella Battista
Antonella Battista
PDPaolo Donateo
Paolo Donateo
ANAlessandro Navazio
Alessandro Navazio
NBNicola Bottoni
Nicola Bottoni
BACKGROUND: Radiofrequency ablation of the cavotricuspid isthmus is currently the first-choice treatment of typical atrial flutter and usually it is performed electively. The purpose of this study was to see whether performing on-line ablation has similar clinical results compared to the conventional strategy. METHODS: Consecutive patients (465) who underwent ablation of the cavotricuspid isthmus for typical atrial flutter (AFL) at our electrophysiology laboratory in the 2008-2017 decade were studied. We evaluated the acute and long-term clinical outcomes of those who were treated electively (337) compared to those who had online ablation (128), that is within 24 hours of presenting to the Department of Cardiology. In patients treated on an emergency basis, a transesophageal echocardiogram was performed to rule atrial thrombi when needed. RESULTS: No significant intraprocedural difference was observed between the 2 patient groups, with comparable acute electrophysiological success (99% vs. 98%) and serious complications. Even at the subsequent 4-year follow-up, there were no significant differences in the recurrence of typical AFL, onset of atrial fibrillation and other clinical events. CONCLUSIONS: Online ablation of typical atrial flutter performed at the time of the clinical presentation of the arrhythmia, was shown to be comparable in terms of procedural safety and clinical efficacy in the short and long term compared to an elective ablation strategy.

5 December 2024 in Forensic Science International
Verified
Journal Article
Closed access
MLMonia Lusetti
Monia Lusetti
ANAntonia Nini
Antonia Nini
MIMatteo Iori
Matteo Iori
ABAntonella Battista
Antonella Battista
NBNicola Bottoni
Nicola Bottoni
FQFabio Quartieri
Fabio Quartieri

12 April 2024 in EP Europace
Verified
Journal Article
Open access
PDF file
JJJesús Jiménez-López
Jesús Jiménez-López
VBVictor Bazan
Victor Bazan
CMCarlos Eduardo González Matos
Carlos Eduardo González Matos
AMAndrea Di Marco
Andrea Di Marco
NBNicola Bottoni
Nicola Bottoni
EVErmengol Valles
Ermengol Valles
Atrioventricular nodal re-entrant tachycardia (AVNRT) is the most common re-entrant supraventricular tachycardia. The Fractionation and WaveSpeed (WS) tools, available with the Omnipolar technology (OT) and the HD-Grid mapping catheter (Abbott Medical™, Abbott Park, IL) may help in the characterization of confluent areas (CAs) of electrogram fractionation and slow conduction in the inferoseptal isthmus,1 in the search for safer AVNRT ablation targets.